Compare COEP & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | BATL |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 17.9M |
| IPO Year | N/A | 2004 |
| Metric | COEP | BATL |
|---|---|---|
| Price | $10.61 | $6.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.4K | ★ 17.4M |
| Earning Date | 03-19-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $166,043,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.32 | $1.00 |
| 52 Week High | $21.41 | $29.70 |
| Indicator | COEP | BATL |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 41.90 |
| Support Level | $8.95 | $1.23 |
| Resistance Level | $13.23 | $29.70 |
| Average True Range (ATR) | 0.97 | 2.61 |
| MACD | -0.10 | -1.73 |
| Stochastic Oscillator | 24.38 | 8.60 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.